A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study
2019 ◽
Vol 155
(3)
◽
pp. 393-399
◽
Roisin E. O’Cearbhaill
◽
Wei Deng
◽
Lee-may Chen
◽
Joseph A. Lucci
◽
Kian Behbakht
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. 5517-5517
Paul Sabbatini
◽
Lee-may Chen
◽
Joseph A. Lucci
◽
Kian Behbakht
◽
Nicola M. Spirtos
◽
...
2007 ◽
Vol 5
(4)
◽
pp. 311-312
S. Makhija
◽
D. Glenn
◽
F. Ueland
◽
D. Dizon
◽
V. Paton
◽
...
2015 ◽
Vol 277
(3)
◽
pp. 903-912
◽
Matthias Pinter
◽
Gregor Ulbrich
◽
Wolfgang Sieghart
◽
Claus Kölblinger
◽
Thomas Reiberger
◽
...
2014 ◽
Vol 23
(3)
◽
pp. 661-670
◽
Bryan K. Kee
◽
Jeffrey S. Morris
◽
Rebecca S. Slack
◽
Todd Crocenzi
◽
Lucas Wong
◽
...
2015 ◽
Vol 26
◽
pp. vi151
M. Petrera
◽
M. Puntoni
◽
A. Parodi
◽
G. Coccia
◽
C. Crosta
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS5604-TPS5604
Agnieszka Michael
◽
Rosemary Lord
◽
Geoff Hall
◽
Louise Hanna
◽
Anjana Anand
◽
...
2007 ◽
Vol 177
(4S)
◽
pp. 35-35
Gianluca Giannarini
◽
Andrea Mogorovich
◽
Girolamo Morelli
◽
Maurizio De Maria
◽
Francesca Manassero
◽
...
2007 ◽
Vol 2007
◽
pp. 378-380
O Schwartz
◽
B Fiedler
◽
M Schilling
◽
P Young
◽
G Kuhlenbäumer
◽
...
2019 ◽
Vol 12
(1)
◽
pp. 48-54
Shilpi Yadav
◽
◽
Vikram Vardhan
◽
Poonam Sangamlal Gupta
◽
EK Ramdas
◽
...
Close
Export Citation Format
Close
Share Document
Close